ClinTec International, a global CRO with a presence in over 40 countries, plans to formally open an office in Istanbul, Turkey.
The office will provide ClinTec’s global team with access to a new patient population, as well as further consolidate the British CRO’s presence in the Middle East and North Africa (MENA) region. The office adds to the company’s current MENA region offices based in Cairo, Egypt, Dubai Health Care City, UAE, and Beirut, Lebanon.
“The launch of this new office in Turkey confirms ClinTec International’s reputation as a truly global provider of quality assured clinical research services,” said Dr. Rabinder Buttar, founder and CEO of ClinTec International. “It also reflects the growing significance of Turkey—and the wider MENA region—to the global clinical research market. We are delighted to be at the forefront of developing expertise in Turkey and the MENA region as a whole.”
The announcement ClinTec’s new Turkey office coincides with the company sponsoring the Partnerships in Clinical Trials Russia-CIS & MENA-Turkey conference held in Istanbul on May 22-23. The conference aims to explore the challenges and opportunities facing companies when conducting clinical trials in the MENA region, and looks for the leading CROs within the region to provide solutions and advice on this complex market.
“Our sponsorship of the conference, coupled with the opening of the Turkey office, further emphasises our belief that ClinTec’s experienced local management team can easily negotiate the fast-moving and constantly evolving trial environment within the region,” said Buttar.